kurkestutis-shutterstock-com-thermo-fisher-
KurKestutis / Shutterstock.com
31 May 2016Americas

Thermo Fisher to acquire electron microscopy company for $4.2bn

Thermo Fisher Scientific has announced that it will buy FEI, an electron microscopy company, for $4.2 billion.

FEI designs, manufactures and supports high-performance electron microscopy workflows that provide images and information at micro-, nano- and picometer scales.

“In life sciences, there is growing adoption of electron microscopy to study the structure of proteins. The technologies we gain with FEI will complement our mass spectrometry leadership, putting Thermo Fisher in the best position to capitalise on this important trend,” said Marc Casper, president and chief executive (CEO) of Thermo Fisher.

He added that the transaction would allow the company’s global scale and commercial reach to extend the use of FEI’s products within its large biopharma customer base.

Don Kania, president and CEO of FEI, said that FEI is pleased to reach the agreement with Thermo Fisher and that the acquisition will offer a number of important benefits to FEI shareholders, customers and employees.


More on this story

Americas
17 May 2016   Thermo Fisher Scientific has agreed a $35 million settlement with Enzo Biochem in a patent infringement fight in a Delaware federal court over a pair of DNA testing patents.
Americas
29 March 2016   Biotechnology company Thermo Fisher Scientific said its potential merger with genomics company Affymetrix is its preferred option to another potential deal.
Americas
26 March 2019   Biotech company Thermo Fisher Scientific has announced plans to acquire Brammer Bio, a viral vector manufacturer for gene and cell therapies, for $1.7 billion.

More on this story

Americas
17 May 2016   Thermo Fisher Scientific has agreed a $35 million settlement with Enzo Biochem in a patent infringement fight in a Delaware federal court over a pair of DNA testing patents.
Americas
29 March 2016   Biotechnology company Thermo Fisher Scientific said its potential merger with genomics company Affymetrix is its preferred option to another potential deal.
Americas
26 March 2019   Biotech company Thermo Fisher Scientific has announced plans to acquire Brammer Bio, a viral vector manufacturer for gene and cell therapies, for $1.7 billion.